Dernières nouvelles
- Ernst, MélanieEmployéCHUL+1 418-525-4444, poste 47044Melanie.Ernst@crchudequebec.ulaval.ca
2705, boulevard Laurier
A-1602
Québec, Québec
Canada G1V 4G2 - Giannakouros, PanagiotaEmployéCHUL+1 418-525-4444, poste 40192Panagiota.Giannak@crchudequebec.ulaval.ca
2705 Boulevard Laurier
A-0121
Québec, QC
Canada G1V 4G2
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Article de revueNat Med, 28 (1), 2022.
Incidence of childhood cancer in Canada during the COVID-19 pandemic
Article de revueCMAJ, 193 (47), 2021.
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes
Article de revueJAMA Oncol, 7 (12), 2021.
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance
Article de revueJ Clin Oncol, 39 (25), 2021.
Screening for asymptomatic diabetes and metabolic comorbidities in pediatric patients during therapy for acute lymphoblastic leukemia
Article de revueJ Pediatr Endocrinol Metab, 34 (5), 2021.
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
Article de revueCancer Discov, 11 (5), 2021.
Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns
Article de revueActa Neuropathol, 140 (5), 2020.
Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC)
Article de revueJ Neurooncol, 149 (1), 2020.
The Management of Young Children With a Likely Infectious Condition Presenting Moderate to Severe Neutropenia
Article de revueJ Pediatr Hematol Oncol, 42 (8), 2020.
Canadian Pediatric Neuro-Oncology Standards of Practice
Article de revueFront Oncol, 10 , 2020.
Projets actifs
- Analyse de la cohorte de neuro-oncologie pédiatrique, du 2024-04-01 au 2027-03-31
- Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients, du 2022-06-21 au 2027-12-25
Projets terminés récemment
- A Phase 2 study of Trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathwa, du 2019-04-01 au 2024-09-30
- Subvention pour la recherche clinique, du 2008-04-01 au 2024-03-31